SAM
Simplify Asset Management Portfolio holdings
AUM
$4.93B
1-Year Est. Return
7.16%
1 Year Est. Return
+7.16%
AUM
$4.93B
AUM Growth
+$3.28B
(+199%)
Holding
137
Top Buys
| 1 | +$3.32B | |
| 2 | +$41.3M | |
| 3 | +$26.1M | |
| 4 |
Simplify Multi-QIS Alternative ETF
QIS
|
+$13.4M |
| 5 |
UnitedHealth
UNH
|
+$8.74M |
Top Sells
| 1 | +$80M | |
| 2 | +$39M | |
| 3 | +$30.7M | |
| 4 |
Simplify Aggregate Bond ETF
AGGH
|
+$30.5M |
| 5 |
NMB
Simplify National Muni Bond ETF
NMB
|
+$29.3M |
Sector Composition
| 1 | Healthcare | 3.63% |
| 2 | Energy | 0.48% |
| 3 | Consumer Discretionary | 0.36% |
| 4 | Technology | 0.19% |
| 5 | Industrials | 0.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Penumbra
PEN
$13.8B
| $2.11M | 0.04% |
+8,342
|
|
||
52
Guardant Health
GH
$14.9B
| $1.94M | 0.04% |
31,100
+4,469
|
|
||
53
Cardinal Health
CAH
$50.6B
| $1.91M | 0.04% |
12,223
-11,006
|
|
||
54
IQVIA
IQV
$41B
| $1.72M | 0.03% |
9,044
+1,104
|
|
||
55
GeneDx Holdings
WGS
$3.14B
| $1.68M | 0.03% |
15,629
-41,071
|
|
||
|
CMPS
56
Compass Pathways
CMPS
$712M
| $1.66M | 0.03% |
+290,000
|
|
||
57
TScan Therapeutics
TCRX
$67.5M
| $1.65M | 0.03% |
904,972
-141,944
|
|
||
58
Biohaven
BHVN
$1.68B
| $1.65M | 0.03% |
109,685
+13,296
|
|
||
59
Danaher
DHR
$167B
| $1.6M | 0.03% |
8,079
-10,166
|
|
||
60
Rithm Capital
RITM
$6.5B
| $1.58M | 0.03% |
142,085
|
|
||
61
Establishment Labs
ESTA
$1.98B
| $1.56M | 0.03% |
+37,948
|
|
||
62
Palantir
PLTR
$409B
| $1.54M | 0.03% |
+8,453
|
|
||
63
HealthEquity
HQY
$7.35B
| $1.5M | 0.03% |
+15,805
|
|
||
64
Abbott
ABT
$213B
| $1.49M | 0.03% |
11,138
+1,344
|
|
||
65
Jasper Therapeutics
JSPR
$43.1M
| $1.45M | 0.03% |
+609,053
|
|
||
66
Revvity
RVTY
$12.8B
| $1.44M | 0.03% |
16,418
+1,992
|
|
||
67
Walmart Inc
WMT
$943B
| $1.43M | 0.03% |
+13,885
|
|
||
|
RFIX
68
Simplify Bond Bull ETF
RFIX
$88M
| $1.41M | 0.03% |
+33,000
|
|
||
69
Zevra Therapeutics
ZVRA
$503M
| $1.4M | 0.03% |
147,000
|
|
||
70
EyePoint Inc
EYPT
$1.3B
| $1.29M | 0.02% |
90,440
+10,968
|
|
||
71
Annaly Capital Management
NLY
$16.5B
| $1.27M | 0.02% |
62,900
|
|
||
72
argenx
ARGX
$49.4B
| $1.22M | 0.02% |
1,659
+192
|
|
||
73
Ligand Pharmaceuticals
LGND
$3.78B
| $1.2M | 0.02% |
6,786
+816
|
|
||
74
Thermo Fisher Scientific
TMO
$235B
| $1.18M | 0.02% |
2,435
+288
|
|
||
75
Pacira BioSciences
PCRX
$801M
| $1.16M | 0.02% |
44,946
-75,897
|
|